AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 73 filers reported holding AMPIO PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $46,000 | -78.7% | 36,000 | -62.5% | 0.03% | -79.7% |
| Q1 2016 | $216,000 | -35.7% | 96,000 | 0.0% | 0.13% | -37.9% |
| Q4 2015 | $336,000 | +21.3% | 96,000 | 0.0% | 0.21% | +15.1% |
| Q3 2015 | $277,000 | +21.5% | 96,000 | 0.0% | 0.19% | +42.0% |
| Q2 2015 | $228,000 | -68.5% | 96,000 | 0.0% | 0.13% | -68.9% |
| Q1 2015 | $723,000 | +177.0% | 96,000 | +26.3% | 0.42% | +180.7% |
| Q4 2014 | $261,000 | -4.0% | 76,000 | -1.3% | 0.15% | -5.1% |
| Q3 2014 | $272,000 | -41.3% | 77,000 | +38.7% | 0.16% | -47.0% |
| Q2 2014 | $463,000 | +32.7% | 55,500 | +0.9% | 0.30% | +26.8% |
| Q1 2014 | $349,000 | -9.4% | 55,000 | +1.9% | 0.24% | -5.2% |
| Q4 2013 | $385,000 | +4.6% | 54,000 | +10.2% | 0.25% | -8.1% |
| Q3 2013 | $368,000 | +73.6% | 49,000 | +33.5% | 0.27% | +67.7% |
| Q2 2013 | $212,000 | – | 36,700 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 3,238,322 | $4,177,000 | 1.35% |
| Noven Financial Group, Inc. | 252,667 | $326,000 | 0.22% |
| Trellus Management Company, LLC | 80,000 | $103,000 | 0.17% |
| Transform Wealth, LLC | 146,692 | $189,000 | 0.08% |
| Fort Point Capital Partners LLC | 121,400 | $157,000 | 0.08% |
| Camelot Portfolios, LLC | 36,000 | $46,000 | 0.03% |
| GHP Investment Advisors, Inc. | 90,000 | $116,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 328,300 | $424,000 | 0.01% |
| JFS WEALTH ADVISORS, LLC | 18,150 | $23,000 | 0.01% |
| WealthTrust Axiom LLC | 10,000 | $12,000 | 0.01% |